England - London • Industry focus
Morgan, Lewis & Bockius UK LLP
Morgan, Lewis & Bockius UK LLP‘s team is noted for advising biotech companies on seed investments, venture capital deals, and obtaining product approvals. Omar Shah has vast expertise in acting for clients in cartel investigations and challenges to European Commission decisions, while Allison Soilihi handles a variety of matters, including private equity transactions and joint ventures. Frances Murphy leads the competition team, often acting for large pharmaceutical companies in challenges to dawn raid search warrants and allegations of market exclusion. The ’exceptional‘ Paul Ranson has broad experience spanning the biotech, pharmaceutical and medical device sectors, often advising clients on pricing, reimbursement, and outsourcing issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Collaborative, helpful, competent, and professional service. Always delivered on time, however complex the issues.'
- 'Paul Ranson is an exceptional lawyer. His breadth of knowledge and experience in the life sciences area is truly staggering. As an individual, he is professional, highly competent and incredibly diligent with any task, big or small.'
Key clients
- StoneCalibre
- Takeda
- Founders and investors in Frankie Health
- Mercury Pharma
- Amdipharm
- Focus Pharma
- AstraZeneca UK
- AMCo Pharma
- Novartis Pharmaceuticals
- Perrigo
Work highlights
- Advised StoneCalibre on its acquisition of Agar Scientific from an investment fund and various management sellers.
- Represented Takeda Pharmaceutical Co. in a series of cross-border transactions with Oak Hill Bio Ltd., a newly formed clinical-stage rare-disease therapeutics company.
- Advised the founders and VC investors of Frankie Health on the sale of Frankie Health to Unmind.
Practice head
The lawyer(s) leading their teams.
Omar Shah